LAVA Therapeutics N.V. (LVTX) Ownership

$1.08

north_east
$0.02 (1.89%)
Day's range
$1.04
Day's range
$1.12

LAVA Therapeutics N.V. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
REDMILE GROUP, LLC 02/14/2025 2.07 M $1.97 M   0.00% 7.73%
SANOFI 02/14/2025 1.92 M $1.83 M   100.00% 7.15%
MERCK & CO., INC. 02/14/2025 1.15 M $1.09 M   100.00% 4.28%
BRUCE & CO., INC. 02/11/2025 771,874 $733,280   0.00% 2.88%
SPHERA FUNDS MANAGEMENT LTD. 02/14/2025 126,328 $120,138   -13.74% 0.47%
PATHWAY FINANCIAL ADVISORS LLC 01/31/2025 102,500 $97,478   0.00% 0.38%
PNC FINANCIAL SERVICES GROUP, INC. 02/07/2025 65,000 $61,815   0.00% 0.24%
TWO SIGMA INVESTMENTS, LP 02/14/2025 48,772 $46,382   -52.54% 0.18%
BNP PARIBAS ARBITRAGE, SNC 02/14/2025 41,800 $39,752   100.00% 0.16%
ENGINEERS GATE MANAGER LP 02/14/2025 31,985 $30,418   169.01% 0.12%
02/14/2025 21,508 $20,454   100.00% 0.08%
VIRTU FINANCIAL LLC 02/11/2025 19,916 $19,000   4.26% 0.07%
MILLENNIUM MANAGEMENT LLC 02/14/2025 19,604 $18,643   62.51% 0.07%
UBS GROUP AG 02/14/2025 18,431 $17,528   1,619.31% 0.07%
HRT FINANCIAL LP 02/14/2025 17,836 $16,000   100.00% 0.07%
GEODE CAPITAL MANAGEMENT, LLC 02/12/2025 16,164 $15,371   45.31% 0.06%
TWO SIGMA SECURITIES, LLC 02/14/2025 13,157 $12,512   100.00% 0.05%
CIBC PRIVATE WEALTH GROUP, LLC 02/12/2025 6,000 $6,120   0.00% 0.02%
02/06/2025 300 $285   100.00% 0.00%
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO 02/11/2025 20 $19   100.00% 0.00%
TANG CAPITAL MANAGEMENT LLC 02/14/2025 0 $0   -100.00% 0.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/14/2025 0 $0   -100.00% 0.00%
TWO SIGMA ADVISERS, LP 02/14/2025 0 $0   -100.00% 0.00%
ALPHA WAVE GLOBAL, LP 02/13/2025 0 $0   -100.00% 0.00%
WALLEYE CAPITAL LLC 02/13/2025 0 $0   -100.00% 0.00%
TSFG, LLC 01/13/2025 0 $0   -100.00% 0.00%

LAVA Therapeutics N.V. institutional Ownership - FAQ's

During the previous two years, 28 institutional investors and hedge funds held shares of LAVA Therapeutics N.V.. The most heavily invested institutionals were:

Redmile Group, LLC: 2.07 M

Sanofi: 1.92 M

Merck & Co., Inc.: 1.15 M

Bruce & Co., Inc.: 771,874

SPHERA FUNDS MANAGEMENT LTD.: 126,328

Pathway Financial Advisors LLC: 102,500

24.11% of LAVA Therapeutics N.V. stock is owned by institutional investors.

Institutional investors have bought a total of 6.50 M shares in the last 24 months. This purchase volume represents approximately $7.02 M in transactions.